Zentalis Pharmaceuticals, Inc. (ZNTL)
1.365
0.00 (0.00%)
USD |
NASDAQ |
Nov 20, 15:43
Zentalis Pharmaceuticals 30-Day Average Daily Volume : 1.354M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.354M |
| November 18, 2026 | 1.348M |
| November 17, 2026 | 1.335M |
| November 16, 2026 | 1.320M |
| November 13, 2026 | 1.371M |
| November 12, 2026 | 1.376M |
| November 11, 2026 | 1.385M |
| November 10, 2026 | 1.374M |
| November 09, 2026 | 1.448M |
| November 06, 2026 | 1.448M |
| November 05, 2026 | 1.440M |
| November 04, 2026 | 1.424M |
| November 03, 2026 | 1.435M |
| November 02, 2026 | 1.425M |
| October 30, 2026 | 1.412M |
| October 29, 2026 | 1.409M |
| October 28, 2026 | 1.397M |
| October 27, 2026 | 1.365M |
| October 26, 2026 | 1.354M |
| October 23, 2026 | 1.344M |
| October 22, 2026 | 1.338M |
| October 21, 2026 | 1.342M |
| October 20, 2026 | 1.328M |
| October 19, 2026 | 1.293M |
| October 16, 2026 | 1.236M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.244M |
| October 14, 2026 | 1.207M |
| October 13, 2026 | 1.206M |
| October 12, 2026 | 1.203M |
| October 09, 2026 | 1.208M |
| October 08, 2026 | 1.202M |
| October 07, 2026 | 1.179M |
| October 06, 2026 | 1.178M |
| October 05, 2026 | 1.184M |
| October 02, 2026 | 1.108M |
| October 01, 2026 | 1.112M |
| September 30, 2026 | 1.108M |
| September 29, 2026 | 1.115M |
| September 28, 2026 | 1.008M |
| September 25, 2026 | 1.118M |
| September 24, 2026 | 1.110M |
| September 23, 2026 | 1.089M |
| September 22, 2026 | 1.054M |
| September 21, 2026 | 1.050M |
| September 18, 2026 | 1.080M |
| September 17, 2026 | 1.061M |
| September 16, 2026 | 1.044M |
| September 15, 2026 | 1.030M |
| September 14, 2026 | 1.010M |
| September 11, 2026 | 1.017M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ARS Pharmaceuticals, Inc. | 2.199M |
| ACADIA Pharmaceuticals, Inc. | 2.367M |
| Alnylam Pharmaceuticals, Inc. | 2.712M |
| Anika Therapeutics, Inc. | 118570.5 |
| Savara, Inc. | 3.222M |